Moleculin Biotech
MBRX
MBRX
12 hedge funds and large institutions have $1.56M invested in Moleculin Biotech in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$212K | |
| 2 | +$30K | |
| 3 | +$29K | |
| 4 |
Morgan Stanley
New York
|
+$4.6K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3K |
Top Sellers
| 1 | -$144K | |
| 2 | -$52K | |
| 3 | -$29.3K | |
| 4 |
Jane Street
New York
|
-$22K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$19K |